196 related articles for article (PubMed ID: 31448789)
1. PIPERACILLIN/TAZOBACTAM IN CONTINUOUS INFUSION VERSUS INTERMITTENT INFUSION IN CHILDREN WITH FEBRILE NEUTROPENIA.
Solórzano-Santos F; Quezada-Herrera A; Fuentes-Pacheco Y; Rodríguez-Coello G; Aguirre-Morales CE; Izelo-Flores D; Muñoz-Hernández O; Miranda-Novales MG; Labra-Zamora MG
Rev Invest Clin; 2019; 71(4):283-290. PubMed ID: 31448789
[TBL] [Abstract][Full Text] [Related]
2. Meropenem versus piperacillin/tazobactam for febrile neutropenia in pediatric patients: efficacy of piperacillin/tazobactam as a 1-h drip infusion four times a day.
Kobayashi R; Sano H; Matsushima S; Hori D; Yanagi M; Kodama K; Suzuki D; Kobayashi K
Int J Hematol; 2021 Mar; 113(3):430-435. PubMed ID: 33170417
[TBL] [Abstract][Full Text] [Related]
3. Meropenem versus piperacillin-tazobactam as empiric therapy for febrile neutropenia in pediatric oncology patients.
Sezgin G; Acipayam C; Ozkan A; Bayram I; Tanyeli A
Asian Pac J Cancer Prev; 2014; 15(11):4549-53. PubMed ID: 24969883
[TBL] [Abstract][Full Text] [Related]
4. A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison with Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patients.
Kamonrattana R; Sathitsamitphong L; Choeyprasert W; Charoenkwan P; Natesirinilkul R; Fanhchaksai K
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2733-2737. PubMed ID: 31554370
[TBL] [Abstract][Full Text] [Related]
5. [Piperacillin/tazobactam plus amikacin vs. piperacilin/tazobactam: treatment for children with febrile neutropenia].
Pacheco-Rosas DO; Peregrino-Bejarano L; López-Aguilar JE; Juan-Shum L; Miranda-Novales MG
Rev Med Inst Mex Seguro Soc; 2019 Jul; 57(2):65-73. PubMed ID: 31617992
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial.
Hagel S; Fiedler S; Hohn A; Brinkmann A; Frey OR; Hoyer H; Schlattmann P; Kiehntopf M; Roberts JA; Pletz MW;
Trials; 2019 Jun; 20(1):330. PubMed ID: 31171029
[TBL] [Abstract][Full Text] [Related]
7. Parameters influencing the pharmacokinetics/pharmacodynamics of piperacillin/tazobactam in patients with febrile neutropenia and haematological malignancy: a prospective study.
Benech N; Dumitrescu O; Conrad A; Balsat M; Paubelle E; Ducastelle-Lepretre S; Labussière-Wallet H; Salles G; Cohen S; Goutelle S; Ader F;
J Antimicrob Chemother; 2019 Sep; 74(9):2676-2680. PubMed ID: 31219562
[TBL] [Abstract][Full Text] [Related]
8. Extended vs Bolus Infusion of Broad-Spectrum β-Lactams for Febrile Neutropenia: An Unblinded, Randomized Trial.
Ram R; Halavy Y; Amit O; Paran Y; Katchman E; Yachini B; Kor S; Avivi I; Ben-Ami R
Clin Infect Dis; 2018 Sep; 67(8):1153-1160. PubMed ID: 29608680
[TBL] [Abstract][Full Text] [Related]
9. Continuous infusion of piperacillin-tazobactam significantly improves target attainment in children with cancer and fever.
Maarbjerg SF; Thorsted A; Friberg LE; Nielsen EI; Wang M; Schrøder H; Albertsen BK
Cancer Rep (Hoboken); 2022 Oct; 5(10):e1585. PubMed ID: 34796702
[TBL] [Abstract][Full Text] [Related]
10. Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison.
Corapcioglu F; Sarper N; Zengin E
Pediatr Hematol Oncol; 2006; 23(3):177-86. PubMed ID: 16517534
[TBL] [Abstract][Full Text] [Related]
11. Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital.
Oztoprak N; Piskin N; Aydemir H; Celebi G; Akduman D; Keskin AS; Gokmen A; Engin H; Ankarali H
Jpn J Clin Oncol; 2010 Aug; 40(8):761-7. PubMed ID: 20427546
[TBL] [Abstract][Full Text] [Related]
12. Meropenem versus piperacillin/tazobactam with or without immunoglobulin as second-line therapy for febrile neutropenia in pediatric patients.
Kobayashi R; Hori D; Sano H; Suzuki D; Kishimoto K; Kobayashi K
J Microbiol Immunol Infect; 2018 Aug; 51(4):473-477. PubMed ID: 28690028
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of piperacillin in febrile children receiving cancer chemotherapy: the impact of body weight and target on an optimal dosing regimen.
Thorsted A; Kristoffersson AN; Maarbjerg SF; Schrøder H; Wang M; Brock B; Nielsen EI; Friberg LE
J Antimicrob Chemother; 2019 Oct; 74(10):2984-2993. PubMed ID: 31273375
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients: protocol for a randomised, multicentre, open-label, superiority clinical trial (BEATLE).
Laporte-Amargos J; Gudiol C; Arnan M; Puerta-Alcalde P; Carmona-Torre F; Huguet M; Albasanz-Puig A; Parody R; Garcia-Vidal C; Del Pozo JL; Batlle M; Tebé C; Rigo-Bonnin R; Muñoz C; Padullés A; Tubau F; Videla S; Sureda A; Carratalà J
Trials; 2020 May; 21(1):412. PubMed ID: 32423462
[TBL] [Abstract][Full Text] [Related]
15. Incidence and Risk Factors of Acute Kidney Injury in Patients Receiving Concomitant Vancomycin and Continuous-Infusion Piperacillin/Tazobactam: A Retrospective Cohort Study.
Blair K; Covington EW
Ann Pharmacother; 2020 Nov; 54(11):1096-1101. PubMed ID: 32406243
[TBL] [Abstract][Full Text] [Related]
16. Comparison of piperacillin tazobactam and cefoperazone sulbactam monotherapy in treatment of febrile neutropenia.
Karaman S; Vural S; Yildirmak Y; Emecen M; Erdem E; Kebudi R
Pediatr Blood Cancer; 2012 Apr; 58(4):579-83. PubMed ID: 21674768
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of febrile neutropenia episodes in children, with a piperacillin-tazobactam and netilmicin combination].
Fouyssac F; Salmon A; Mansuy L; Schmitt C; Bordigoni P; Chastagner P
Med Mal Infect; 2005 Jun; 35(6):357-62. PubMed ID: 15982848
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of tazobactam/piperacillin as an empirical treatment for the patients of adult and child with febrile neutropenia in Japan.
Tamura K; Akiyama N; Kanda Y; Saito M
J Infect Chemother; 2015 Sep; 21(9):654-62. PubMed ID: 26141812
[TBL] [Abstract][Full Text] [Related]
19. A clinical evaluation of efficacy and safety of cefepime monotherapy versus piperacillin-tazobactam in patients of paediatric age group with febrile neutropenia in a tertiary care centre of north India.
Aamir M; Abrol P; Sharma D; Punia H
Trop Doct; 2016 Jul; 46(3):142-8. PubMed ID: 26612093
[TBL] [Abstract][Full Text] [Related]
20. A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III.
Lipman J; Brett SJ; De Waele JJ; Cotta MO; Davis JS; Finfer S; Glass P; Knowles S; McGuinness S; Myburgh J; Paterson DL; Peake S; Rajbhandari D; Rhodes A; Roberts JA; Shirwadkar C; Starr T; Taylor C; Billot L; Dulhunty JM
Crit Care Resusc; 2019 Mar; 21(1):63-68. PubMed ID: 30857514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
